Temozolomide Capsule
Product Images NDC 75834-142

Product Visual Gallery

This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Temozolomide (NDC 75834-142). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nivagen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mg-14count-label.jpg (100mg 14count Label)

Label for Temozolomide Capsules, USP 100 mg, oral administration, manufactured for Nivagen Pharmaceuticals, Inc. The label indicates 14 capsules per package, with a warning that the drug is cytotoxic and requires careful adherence to directions. Storage instructions specify 25°C with allowed excursions. The product is made in Germany and includes a barcode and manufacturer contact information.*

FDA Label Image

100mg-5count-label.jpg (100mg 5count Label)

Label for Temozolomide Capsules, USP 100 mg for oral administration by Nivagen Pharmaceuticals, Inc. The label highlights the strength 100 mg and indicates the product is cytotoxic requiring reading of accompanying directions. It states each capsule contains 100 mg temozolomide and provides storage instructions and manufacturer details, including Nivagen Pharmaceuticals in Sacramento, CA, and made in Germany. The package contains 5 capsules.*

FDA Label Image

100mg14c-carton.jpg (100mg14c Carton)

Packaging label for Temozolomide Capsules, USP 100 mg for oral administration. The label shows the product name and strength prominently in blue and orange text. It includes storage instructions, a warning box for pharmacists about special dispensing information, and a barcode. The label indicates the product contains 14 capsules and is manufactured for Nivagen Pharmaceuticals, Inc. in Sacramento, CA, USA. Safety instructions warn against opening capsules due to cytotoxicity.*

FDA Label Image

100mg5c-carton.jpg (100mg5c Carton)

Packaging label for Temozolomide Capsules, USP 100 mg oral capsules. The label includes the NDC 75834-143-05, indicates storage conditions at 25°C, and contains warnings such as cytotoxic handling and pharmacist dispensing instructions. The package contains 5 capsules and is manufactured for Nivagen Pharmaceuticals, Inc., Sacramento, CA, Made in Germany.*

FDA Label Image

140mg-14count-label.jpg (140mg 14count Label)

Label for Temozolomide Capsules, USP 140 mg by Nivagen Pharmaceuticals, Inc., containing 14 oral capsules. The label highlights the cytotoxic nature of the drug, storage instructions at 25°C with permitted excursions, and advises use of tight, light-resistant containers. Manufactured in Germany with contact information provided.*

FDA Label Image

140mg-5count-label.jpg (140mg 5count Label)

Label for Temozolomide Capsules, USP 140 mg oral capsules by Nivagen Pharmaceuticals, Inc. The label includes storage instructions, a note on cytotoxicity, and a package count of 5 capsules. The label features the Nivagen logo and contact information, with a barcode and lot/expiration fields.*

FDA Label Image

140mg14c-carton.jpg (140mg14c Carton)

Packaging label for Temozolomide Capsules, USP 140 mg, an oral capsule product manufactured by Nivagen Pharmaceuticals, Inc. The label shows the product name and strength prominently, with a total of 14 capsules per package. Storage instructions and pharmacist dispensing warnings are also included, along with a barcode and manufacturer contact information.*

FDA Label Image

140mg5c-carton.jpg (140mg5c Carton)

Packaging label for Temozolomide Capsules, USP 140 mg by Nivagen Pharmaceuticals, Inc. The box contains 5 oral capsules. The label includes storage instructions, a cautionary note for pharmacists regarding special dispensing information, and cytotoxic handling warnings. The product is marked Rx Only and manufactured in Germany.*

FDA Label Image

180mg-14count-label.jpg (180mg 14count Label)

Label for temozolomide Capsules USP 180 mg oral capsule by Nivagen Pharmaceuticals, Inc. The label indicates the product contains 14 capsules, is cytotoxic, and includes storage instructions and manufacturer contact details. The label shows the NDC number 75834-145-14 and mentions the capsules are made in Germany.*

FDA Label Image

180mg-5count-label.jpg (180mg 5count Label)

Label for Temozolomide Capsules, USP 180 mg oral capsules by Nivagen Pharmaceuticals, Inc. The label shows the NDC 75834-145-05, indicates cytotoxic status with a warning to read directions carefully, and states the package contains 5 capsules. It advises storage at controlled room temperature and provides manufacturer information including location and contact.*

FDA Label Image

180mg14c-carton.jpg (180mg14c Carton)

Temozolomide Capsules, USP 180 mg box label for oral administration by Nivagen Pharmaceuticals, Inc. It contains 14 capsules. The label includes storage instructions, pharmacist dispensing information, a barcode, and a caution that capsules should not be opened due to cytotoxicity. Manufactured in Germany with contact details provided.*

FDA Label Image

180mg5c-carton.jpg (180mg5c Carton)

Packaging label for temozolomide capsules, USP 180 mg by Nivagen Pharmaceuticals, Inc. The label states the product is for oral administration and comes in a package of 5 capsules. Storage conditions specify 25°C with allowed excursions. The label includes warnings about the cytotoxic nature, advice not to open capsules, and instructs swallowing whole. Manufacturer information and barcodes are visible.*

FDA Label Image

20mg-14count-label.jpg (20mg 14count Label)

Label for temozolomide capsules USP, 20 mg strength, for oral administration. The label states the product is cytotoxic and advises to read directions carefully. It is a prescription drug with 14 capsules per package. Manufactured for Nivagen Pharmaceuticals, Inc., Sacramento, CA, and made in Germany. Storage instructions and a barcode are also present.*

FDA Label Image

20mg-5count-label.jpg (20mg 5count Label)

Label for temozolomide capsules USP 20 mg for oral administration by Nivagen Pharmaceuticals, Inc. The label includes storage instructions, a cytotoxic warning, and indicates the package contains 5 capsules. It displays the NDC 75834-142-05 and manufacturing details including a toll-free number and 'Made in Germany'.*

FDA Label Image

20mg14c-carton.jpg (20mg14c Carton)

Packaging label for Temozolomide Capsules, USP 20 mg oral capsules by Nivagen Pharmaceuticals, Inc. The carton contains 14 capsules and includes storage instructions and pharmacist dispensing information. The label states the product is for oral administration and emphasizes careful handling due to cytotoxicity.*

FDA Label Image

20mg5c-carton.jpg (20mg5c Carton)

Packaging label for Temozolomide Capsules, USP 20 mg by Nivagen Pharmaceuticals, Inc. The label is for oral capsules, indicating a quantity of 5 capsules per package. The design includes dosage information, storage conditions, and a barcode. The packaging instructs special dispensing information and cautions that the capsules are cytotoxic, advising not to open and to swallow whole.*

FDA Label Image

250mg-5count-label.jpg (250mg 5count Label)

Label for Temozolomide Capsules USP 250 mg by Nivagen Pharmaceuticals, Inc. The label includes dosing warnings such as 'Cytotoxic - Read accompanying directions carefully' and specifies oral administration of 5 capsules. It contains storage instructions and manufacturer details including a toll-free number and 'Made in Germany' note, plus barcodes and revision date 03/2021.*

FDA Label Image

250mg5c-carton.jpg (250mg5c Carton)

Packaging label for temozolomide capsules, USP 250 mg oral capsules by Nivagen Pharmaceuticals, Inc. The label indicates a package size of 5 capsules. It includes storage instructions, pharmacist dispensing information, and a warning that capsules should not be opened due to cytotoxicity. The label states the capsules contain 250 mg temozolomide and provides manufacturer contact information and a barcode.*

FDA Label Image

5mg-14count-label.jpg (5mg 14count Label)

Label for Temozolomide Capsules, USP 5 mg oral capsules. The label states the product is cytotoxic and for prescription use only, containing 14 capsules. It is manufactured for Nivagen Pharmaceuticals, Inc., Sacramento, CA, and made in Germany. Storage instructions and a barcode are also shown.*

FDA Label Image

5mg-5count-label.jpg (5mg 5count Label)

Label for Temozolomide Capsules, USP 5 mg oral capsules. The label shows the product name, strength (5 mg), and route of administration. It includes warnings to read directions carefully as the drug is cytotoxic, the manufacturer Nivagen Pharmaceuticals, Inc., and storage instructions at 25°C. The package contains 5 capsules and features barcodes and manufacturing details.*

FDA Label Image

5mg14c-carton.jpg (5mg14c Carton)

Temozolomide Capsules, USP 5 mg oral capsules packaging label by Nivagen Pharmaceuticals, Inc. The label includes the strength (5 mg) and highlights the oral administration route. It specifies storage conditions at 25°C (77°F) with permitted excursions and contains warnings about cytotoxicity and handling. The package contains 14 capsules and features barcodes and a note to pharmacists about special dispensing information.*

FDA Label Image

5mg5c-carton.jpg (5mg5c Carton)

Temozolomide Capsules, USP 5 mg oral capsule packaging label from Nivagen Pharmaceuticals, Inc. The label includes storage instructions, a warning to pharmacists about special dispensing information, and cytotoxic warnings advising not to open capsules and to swallow whole. The package contains 5 capsules and is marked with barcodes and an NDC number 75834-132-05.*

FDA Label Image

Figure1 (Figure 1)

A Kaplan-Meier overall survival curve comparing two groups, RT + TMZ and RT Only, in an ITT population over 40 months. The y-axis represents survival probability, and the x-axis shows time from randomization in months. The graph includes hazard ratio (HR 0.63, 95% CI 0.52-0.75) and a log-rank P-value <0.0001, indicating statistical analysis results.*

FDA Label Image

Structure (Structure)

Chemical structure of temozolomide showing its molecular arrangement with labeled atoms including nitrogen (N), oxygen (O), methyl group (CH3), and amide (CONH2) groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.